Portola Pharmaceuticals
UEI: FH2MKRASLYM3
• CAGE: 5XNN2
Overview
Parent Awardee
Company Description
Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.
Name
Portola Pharmaceuticals
Website
Headquarters
South San Francisco, CA
United States
United States
Most Recent Award
Jan. 1, 2020
Calculating
Federal grant recipient
PORTOLA PHARMACEUTICALS, INC.
(UEI FH2MKRASLYM3, CAGE 5XNN2)
is headquartered in South San Francisco CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in September 2003 and
federally registered in
March 2010.
Federal Award Analysis
Portola Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PORTOLA PHARMACEUTICALS, INC.
UEI
FH2MKRASLYM3
CAGE Code
5XNN2
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 2, 2003
Initial Registration
March 17, 2010
Last Registration
Nov. 17, 2022
Registration Activation
Oct. 26, 2021
Registration Expiration
Nov. 17, 2022
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Portola Pharmaceuticals
GSA Schedules and Price Lists
- Portola Pharmaceuticals
- PoP: 12/31/19 - 5/14/22 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)